Crown Bioscience

About:

CrownBio is helping provide clarity of action in the fight against cancer and diabetes.

Website: http://www.crownbio.com

Twitter/X: crownbioscience

Top Investors: OrbiMed, Qiming Venture Partners, Lilly Asia Ventures, Argonaut Private Equity, CDIB Capital

Description:

CrownBio is a Cutting Edge Translational Technology Company Making Precision Medicine a Reality CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, cardiovascular, and metabolic disease Drug Discovery. Their premier Translational Platforms for cancer and metabolic disease help our clients accelerate their new drug development programs. CrownBio develops world-leading preclinical efficacy models and provides both in vitro and in vivo testing services and preclinical research products. They are a global company with facilities across the world in the United States, United Kingdom, China, and Taiwan.

Total Funding Amount:

$61.1M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Santa Clara, California, United States

Founded Date:

2006-01-01

Contact Email:

busdev(AT)crownbio.com.

Founders:

Alex Wu

Number of Employees:

251-500

Last Funding Date:

2014-05-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai